Non-Current Assets

Accumulated Goodwill Impairment Losses

Merck & Co. Accumulated Goodwill Impairment Losses remained flat by 0.0% to $531.00M in Q4 2025 compared to the prior quarter. Year-over-year, this metric was flat by 0.0%, from $531.00M to $531.00M. Over 5 years (FY 2020 to FY 2025), Accumulated Goodwill Impairment Losses shows relatively stable performance with a 0.0% CAGR.

Analysis

StatementBalance Sheet Statement
SectionNon-Current Assets
First reportedQ4 2014
Last reportedQ4 2025Feb 24, 2026
Metric ID: accumulated_goodwill_impairment

Historical Data

5 periods
 Q4 '21Q4 '22Q4 '23Q4 '24Q4 '25
Value$531.00M$531.00M$531.00M$531.00M$531.00M
QoQ Change+0.0%+0.0%+0.0%+0.0%
YoY Change+0.0%+0.0%+0.0%+0.0%
Range$531.00M$531.00M
CAGR+0.0%
Avg YoY Growth+0.0%
Median YoY Growth+0.0%
Current Streak4+ quarters growth

Accumulated Goodwill Impairment Losses at Other Companies

Frequently Asked Questions

What is Merck & Co.'s accumulated goodwill impairment losses?
Merck & Co. (MRK) reported accumulated goodwill impairment losses of $531.00M in Q4 2025.
How has Merck & Co.'s accumulated goodwill impairment losses changed year-over-year?
Merck & Co.'s accumulated goodwill impairment losses decreased by 0.0% year-over-year, from $531.00M to $531.00M.
What is the long-term trend for Merck & Co.'s accumulated goodwill impairment losses?
Over 5 years (2020 to 2025), Merck & Co.'s accumulated goodwill impairment losses has grown at a 0.0% compound annual growth rate (CAGR), from $531.00M to $531.00M.